SGLT2 Inhibitor-Induced Ketoacidosis in a Patient Without Diabetes

Diabetes Care. 2024 Jan 1;47(1):e4-e5. doi: 10.2337/dc23-1903.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetic Ketoacidosis* / chemically induced
  • Humans
  • Ketosis* / chemically induced
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects

Substances

  • Sodium-Glucose Transporter 2 Inhibitors